Microsoft Stock: Technically Compelling, Too Rich For Me
Microsoft posts record numbers and the stock reclaims its 200-day line. Still, there's an elephant in the room for me that turns the valuation into a risk. Why I'm not buying.
Astera Labs: Up 342% in One Quarter. Here's Why I'm Still Not Buying.
Five customers generate 90% of revenue, and the P/E sits above 90 based on 2028 estimates. The best NASDAQ-100 stock of recent months has a profile few people question. I did.
Microsoft Stock: Technically Compelling, Too Rich For Me
Microsoft posts record numbers and the stock reclaims its 200-day line. Still, there's an elephant in the room for me that turns the valuation into a risk. Why I'm not buying.
Astera Labs: Up 342% in One Quarter. Here's Why I'm Still Not Buying.
Five customers generate 90% of revenue, and the P/E sits above 90 based on 2028 estimates. The best NASDAQ-100 stock of recent months has a profile few people question. I did.
Micron Technology: The best stock of the week. I'm still not buying.
Micron Technology delivered this week: record quarterly results and what looks like a genuine shift in its business model. And yet I'm sitting on the sidelines. I'm starting to wonder whether the AI boom is showing its first cracks.
Uranium Investment: These Are the Price Levels That Will Make Me Buy More
438 reactors today. Hundreds more coming. The fuel they all need is already in short supply. I am buying the commodity directly, not the stocks. Here is why.
Cybersecurity companies are not all created equal. Qualys has the margins, the customers, and the staying power. The valuation doesn't reflect any of that.